The largest database of trusted experimental protocols

1 plus kit

Manufactured by Hypoxyprobe
Sourced in United States

The Hypoxyprobe-1 Plus Kit is a laboratory equipment used for detecting and measuring hypoxic conditions in biological samples. It contains the necessary components to perform immunohistochemical and immunofluorescent analyses to identify and quantify hypoxic cells.

Automatically generated - may contain errors

50 protocols using 1 plus kit

1

Hypoxia Imaging in 4T1 Tumor Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence assay of HIF‐1α and hypoxia marker was performed. 4T1 tumor bearing mice with tumor volume of about 200 mm3 were selected and i.v. injected with PpIX, P‐TH, and OP‐TH (2.5 mg kg−1 PpIX), respectively. The tumor was dissected surgically 12 h post‐injection. After being embedded in an optimal cutting temperature compound (OCT), tumors were cut into tissue sections (7 µm) on a freezing microtome and attached to the slide. All tissues were incubated with primary anti‐Hif‐1α antibody for 2 h, and washed thrice with PBS. All samples were washed thrice with PBS containing 0.1% tween‐20 after being treated with secondary Alexa Fluor488‐conjugated goat anti‐rabbit IgG H&L antibody for 1 h. Finally, all samples were dyed with DAPI and recorded by CLSM. In the immunofluorescence study of hypoxia marker, the pretreatment of mice was similar to the above method. 6 h after the i.p. injection of pimonidazole HCl (Hypoxyprobe‐1 plus kit, Hypoxyprobe Inc., USA 60 mg kg−1), the tumors were dissected and made into frozen tissue sections (7 µm). First, tumor tissues were treated with anti‐pimonidazole antibody (dilution rate 1:200, Hypoxyprobe‐1 plus kit). Next, horseradish peroxidase linked to goat anti‐mouse secondary antibody (dilution rate 1:200) was added according to the manufacturer's instructions. At last, all samples were stained with DAPI and observed under CLSM.
+ Open protocol
+ Expand
2

Hypoxia Alleviation in Tumor Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the hypoxia alleviating ability of LIH in vivo, both xenograft and orthotopic CT-26 tumor model were used. The tumor bearing mice were randomly divided into three groups and were intravenously injected with saline, LI (100 μL, 6.0 mg total lipid per mL), and LIH (100 μL, 6.0 mg total lipid per mL and 10 mg Hb per mL) for three times (one injection per day), respectively. The tumors were dissected at 24 h after the last injection and were cut into 5 μm slices. For the detection of hypoxia in tumors, the tumor slides were stained using a commercial Hypoxyprobe-1 plus kit (Hypoxyprobe, Burlington, MA) following the protocol provided. For the detection of HIF-1α and VEGF, the tumor slides were incubated with polyclonal rabbit anti-HIF-1α antibody (dilution1:100) and VEGF antibody (dilution 1:100), respectively. After washing with PBS, the HIF-1α, and VEGF antibody was detected using FITC conjugated goat anti-rabbit immunoglobulin G, followed by observation using a confocal microscope.
To further investigate how long the alleviated tumor hypoxia state could maintain, the tumors were dissected at day 2, 4, and 7 after the last injection of LIH. The expression of HIF-1α and VEGF in tumor was determined using the methods as the mentioned above and the degree of hypoxia in tumor also was analyzed using Hypoxyprobe-1 plus kit.
+ Open protocol
+ Expand
3

Hypoxia Detection in Mice Using Pimonidazole

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine hypoxia, mice were given the hypoxia marker pimonidazole HCL (60 mg/mL) (Hypoxyprobe‐1 Plus Kit; Hypoxyprobe, Burlington, MA, USA) i.p. 2 h before they were killed. Pimonidazole is reductively activated in hypoxic cells that have a pO2 level ≤10 mmHg and forms stable adducts with thiol groups in proteins, peptides, and amino acids. The formation of pimonidazole protein adducts was detected by FITC‐conjugated antibody (1:200) provided in the Hypoxyprobe‐1 Plus Kit.
+ Open protocol
+ Expand
4

Quantifying Tumor Hypoxia and Vasculature

Check if the same lab product or an alternative is used in the 5 most similar protocols
The variation of hypoxia degree within tumor microenvironment after 24 h post injection of OxgeMCC-r SAE was investigated with immunofluorescence staining. At 90 min before tumors were surgically excised, pimonidazole hydrochloride (Hypoxyprobe-1 plus kit, Hypoxyprobe, USA) was intraperitoneally injected into mice at a dose of 30 mg kg−1. The collected tumor slices were firstly stained with mouse anti-pimonidazole monoclonal antibody (dilution 1:200, Hypoxyprobe) and rat-anti mouse CD31 primary antibody (dilution 1:200, Biolegend) to mark tumor hypoxia regions and blood vessels, respectively. Thereafter, the slices were stained with Alex 488-conjugated goat anti-mouse secondary antibody (Jackson Inc.) and rhodamine-conjugated donkey anti-rat secondary antibody (Jackson Inc.), respectively. The nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI, Invitrogen). The final images of stained slices were obtained using a confocal laser scanning microscope (Zeiss LSM 710).
+ Open protocol
+ Expand
5

Hypoxia Visualization in 4T1 Tumor-Bearing Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunohistochemistry analysis, 4T1 tumor-bearing mice were intravenously injected with TiH1.924-PVP (20 mg·kg−1). At 8 h p.i., tumors on these mice were exposed to the 1064-nm laser irradiation for 20 min with their temperature maintained at ~45 °C. Then immediately, tumors were surgically excised for hypoxia staining assay using the Hypoxyprobe-1 plus kit (Hypoxyprobe Inc) following the standard protocol61 (link),62 . Anti-pimonidazole mouse monoclonal antibody conjugated with FITC (FITC-Mab1, Hypoxyprobe Inc.; Cat. No.: HP2-100Kit; Lot No.: 04-11-19; Clone: 4.3.11.3; Dilution: 1:200) and Alex 488-conjugated goat anti-mouse secondary antibody (Jackon Inc., Cat. No.: 115-545-003, Lot No.: 146108, RRID: AB_2338840; dilution: 1:200) for hypoxia staining. Rat anti-CD31 mouse monoclonal antibody (Biolegend Inc., Cat. No.: 102402, Lot No.: B226360, Clone: 390; dilution: 1:100) and Rhodamine-conjugated donkey anti-rat secondary antibody (Jackon Inc. Cat. No.: 712-025-150, Lot No.: 147079, RRID: AB_2340635; Dilution: 1:200) for blood vessel staining.
+ Open protocol
+ Expand
6

Hypoxia Imaging in Tumor-Bearing Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 Balb/c tumor-bearing nude mice (n = 3/group) were i.v. injected with MnO2 NPs or saline (control). After 24 h, animals received an intraperitoneal injection of hypoxia marker pimonidazole HCl solution (60 mg/kg) (Hypoxyprobe-1 plus kit, Hypoxyprobe Inc., USA), and were sacrificed 60 min later. Tumor tissues were quickly harvested, embedded in OCT medium, and snap frozen. Consecutive 5 μm sections were cut at the largest circumference of the tumor. After thawing, the sections were fixed in cold acetone for 10 min and incubated overnight at 4 ℃ with the FITC-labeled mouse monoclonal anti-pimonidazole antibody (clone 4.3.11.3; FITC-MAb1) diluted in PBS containing 0.1% bovine serum albumin c and 0.1% Tween 20. Subsequently, the sections were incubated for 90 min with anti-FITC HRP, followed by incubation with Hoechst 33342 for nuclei location. Slides were scanned with a fluorescence microscope (Olympus, Shinjuku, Tokyo, Japan) and images were analyzed with ImageJ 7.0 software.
+ Open protocol
+ Expand
7

Quantifying Tumor Hypoxia via Hypoxyprobe

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor hypoxia was determined using the Hypoxyprobe-1 Plus Kit (Hypoxyprobe) as previously descrived13 (link),14 (link). Mice were injected intravenously with pimonidazole HCl (60 mg kg−1). Tumors were excised, and frozen sections were fixed with chilled acetone and stained with anti-pimonidazole adduct FITC-conjugated antibody according to the manufacturer’s instructions. Sections were imaged using an Axio Imager microscope (Zeiss) equipped with an AxioCam 506 monochrome CCD camera (Zeiss). Whole tumors were analyzed by light sheet fluorescence imaging using the Lightsheet Z.1 LSFM system (Zeiss).
+ Open protocol
+ Expand
8

Bovine Hemoglobin-based Nanoparticles for Cancer Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bovine hemoglobin and GSH were purchased from Aladdin (Shanghai, China); transferrin and doxorubicin hydrochloride salt were supplied by MACKLIN (Shanghai, China); PpIX was bought from Energy Chemical (Shanghai, China); ROS detection Kit was obtained from Beyotime (Jiangsu, China); TFRs was purchased from Mei Mian Biotechnology Co., Ltd. (Jiangsu, China); Mouse ALT Kit, BUN Kit, CRE Kit, AST Kit were obtained from Nanjing Jiancheng Bioengineering Institute (Jiangsu, China); Hemoglobin was supported by ToYongBio Tech Inc. (Shanghai, China); Monolith RED‐NHS protein labeling kit were purchased from NanoTemper Technologies GmbH; Hypoxyprobe‐1 plus kit was purchased from Hypoxyprobe Inc.; JC‐1 assay kit, apoptosis assays kit, and Calcein/ PI cell viability assay kit were obtained from keygen biotech (Jiangsu, China).
+ Open protocol
+ Expand
9

Mapping Hypoxia and HIF-1α in Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypoxic regions and HIF-1α expression within tumors was studied using s.c. injections of transformed MEFs into the flank of 4–6-week-old athymic nude Foxn1nu/nu mice as described in [21 (link)]. Tumor growth was monitored for 18 days. Hypoxic regions were detected using the Hypoxyprobe-1 Plus Kit as per manufacturer’s protocol (Hypoxyprobe, Inc). Briefly, the probe was injected intravenously (60 mg/kg body weight) 90 min before tumor-bearing mice were sacrificed. Tumors were harvested, embedded in Tissue-Tek O.C.T. compound (VWR) and cryopreserved. 8 μm cryosections were fixed for 20 min in ice-cold Methanol/Acetone (1:1), permeabilized in 0.2% TritonX/PBS, and blocked in 5% Goat serum/PBST for 30 min before stained with anti-HIF-1α (1:100; Novus). Sections were incubated with Alexa568-conjugated anti-rabbit IgG antibody (1:500, Thermo Scientific). Thereafter, sections were stained with FITC-conjugated hypoxyprobe-1 monoclonal antibody (1:500, Hypoxyprobe™) and mounted using ProLong® Diamond Antifade Mountant (Molecular Probes™). Co-localization of Hypoxic regions and HIF-1a-positive regions were determined using ImageJ softwear. All animal experiments were conducted in accordance with Karolinska Institutet guidelines and approved by Stockholm’s North Ethical Committee of Animal Research (ethical permit N214/15).
+ Open protocol
+ Expand
10

Hypoxia Staining in Precision-Cut Lung Slices

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypoxia staining was performed using the Hypoxyprobe-1 Plus Kit (Hypoxyprobe, Burlington, USA) according to the manufacturer's instructions. In brief, PCLS were incubated with 200 μM hypoxyprobe (2-pimonidazole HCl in 0,9% saline water) for 1 h prior to harvesting. Thereafter, PCLS were fixed in 4% formaldehyde/PBS and imbedded in paraffin. Paraffin sections of 4 μm thickness were deparaffinized and antigens were retrieved by incubation in citrate buffer (10 mM, pH = 6) for 20 min at 90 °C. After that, sections were incubated with the first antibody for 60 min at room temperature. Endogenous peroxidase activity was inhibited by incubation of the sections with 0.3% H 2 O 2 in methanol for 20 min. Afterwards, the secondary antibody was applied for 30 min. Normal rat serum (NRS) (5%) was added to the secondary antibody to block non-specific binding. Antigen-antibody complexes were visualized by staining with di-aminobenzidine (DAB) chromogen with H 2 O 2 for 20 min. Sections were counterstained with hematoxylin for 1 min. Following dehydration, the slides were covered with a cover slip using Depex and were examined under the microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!